Monkeypox Treatment Market Growth, Share, Trends, Opportunities and Future Outlook 2022-2032
Monkeypox Treatment Market Size- By Treatment, By Product Type, By Dosage Form, By Route of Administration, By Age, By Gender, By Prescription Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032
| Published: Jan-2023 | Report ID: HLCA2303 | Pages: 1 - 248 | Formats*: |
| Category : Healthcare | |||
Global Monkeypox Treatment Market Overview
According to SPER Market Research, the Global Monkeypox Treatment Market is estimated to reach USD 0.23 billion by 2032 with a CAGR of 10.37%.
The monkeypox virus is the source of this uncommon but severe illness. Since monkey pox is a contagious disease, it can be spread by sick people, animals, or even contaminated objects. The monkeypox virus results in skin lesions and rashes on every part of the diseased body. Monkeypox symptoms and signs include fever, swollen lymph nodes, aches and chills, and muscle pain.
The market for monkeypox is anticipated to grow quickly in terms of CAGR. The increase in monkeypox cases worldwide is the main factor driving monkeypox market revenue growth.One of the main factors propelling the growth of the monkeypox market is the increase in monkeypox prevalence as a result of the rise in viral infections brought on by the monkeypox virus. The monkeypox virus can cause viral infection in people with weakened immune systems. Increase in numerous chronic illnesses and dermatological conditions like eczema, which causes weakened immunity and increases the risk of contracting the monkeypox virus, leads to the expansion of the monkeypox market.The market expansion of monkeypox treatments is supported by increased research and development for the treatment of monkeypox as well as rising global demand for the therapy.
Impact of COVID-19 on the Global Monkeypox Treatment Market
The recent COVID 19 pandemic has resulted in weakened immunity in those affected, which raises the risk of monkeypox virus infection. Monkeypox market expansion was boosted by a large population that was infected with COVID 19. Businesses across all industries are struggling financially as a result of the global lockdown caused by the corona virus (COVID 19) epidemic. Global supply chains and manufacturing operations have been affected as a result of lockdowns imposed by national authorities, travel restrictions, and other COVID-19 safety measures. However, the market for treating monkeypox is barely impacted by COVID 19.However, due to a significant lack of medical supplies and raw materials, manufacturing locations located in the worst-hit nations have been badly impacted. This has disrupted the world's supply chains.The Food and Drug Administration (FDA) of the United States is still keeping tabs on the supply chain. In order to improve the supply chain of medical products in the future, the Center for Drug Evaluation and Research (CDER) Drug Shortage Staff asked manufacturers to assess their entire supply chain of various products, including ethanol, EDTA (Ethylenediaminetetraacetic acid), and vaccine manufacturing equipment, among others.
-011405418012023.jpg)
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Treatment, By Product Type, By Dosage Form, By Route of Administration, By Age, By Gender, By Prescription Type, By End User |
| Regions covered | Asia Pacific, Europe, Middle East and Africa, North America, Latin America |
| Companies Covered | Bavarian Nordic, Chimerix, CIDIC Co., Ltd., EMERGENT, Hetero, Olon S.p.A, Piramal Pharma Solutions, SIGA Technologies, Teva Pharmaceutical Industries Ltd. |
Target Audience-
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global Monkeypox Treatment Market Segmentation:
1. By Treatment:
- Medications
- Vaccine
2. By Product Type:
- Creams
- Gels
- Injectable
- Ointment
- Tablets
3. By Dosage Form:
- Liquid
- Semi Solid
- Solid
4. By Route of Administration:
- Oral
- Parenteral
- Topical
5. By Age:
- Adults
- Geriatrics
- Paediatrics
6. By Gender:
- Female
- Male
- Others
7. By Prescription Type:
- Over the counter (OTC) drugs
- Prescription (Rx) drugs
8. By End User:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
9. By Region:
- Asia-Pacific
- Europe
- Middle East & Africa
- North America
- Latin America
Key Topics Covered in the Report:
- Size of Global Monkeypox Treatment Market (FY’2019-FY’2032)
- Overview of Global Monkeypox Treatment Market
- Segmentation of Global Monkeypox Treatment By Treatment (Medications, Vaccine, Vaccinia Immune Globulin)
- Segmentation of Global Monkeypox Treatment Market By Product Type (Creams, Gels, Injectable, Ointment, Tablets)
- Segmentation of Global Monkeypox Treatment Market ByDosage Form (Liquid, Semi Solid, Solid)
- Segmentation of Global Monkeypox Treatment Market By Route of Administration (Oral, Parenteral, Topical)
- Segmentation of Global Monkeypox Treatment Market By Age (Adults, Geriatrics, Paediatrics)
- Segmentation of Global Monkeypox Treatment Market By Gender (Female, Male, Others)
- Segmentation of Global Monkeypox Treatment Market By Prescription Type (Over the counter drugs, Prescription drugs)
- Segmentation of Global Monkeypox Treatment Market By End User (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
- Statistical Snap of Global Monkeypox Treatment Market
- Growth Analysis of Global Monkeypox Treatment Market
- Problems and Challenges in Global Monkeypox Treatment Market
- Competitive Landscape in the Global Monkeypox Treatment Market
- Impact of COVID-19 and Demonetization on Global Monkeypox Treatment r Market
- Details on Recent Investment in Global Monkeypox Treatment Market
- Competitive Analysis of Global Monkeypox Treatment Market
- Major Players in the Global Monkeypox Treatment Market
- SWOT Analysis of Global Monkeypox Treatment Market
- Global Monkeypox Treatment Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data2.1.2 Primary data2.1.3 SPER’s internal database2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers4.1.2 Restraints4.1.3 Opportunities4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Monkeypox Treatment Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape5.2.2 Economic landscape5.2.3 Social landscape5.2.4 Technological landscape5.2.5 Environmental landscape5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers5.3.2 Bargaining power of Buyers5.3.3 Threat of Substitute5.3.4 Threat of new entrant5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Global Monkeypox Treatment Manufacturing Base Distribution, Sales Area, Product Type6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Monkeypox Treatment Market
7. Global Monkeypox Treatment Market, By Treatment, 2019-2032 (USD Million)
7.1 Medications
7.1.1 Analgesics7.1.2 Antipruritic or Anti-itch drugs7.1.3 Antipyretics7.1.4 Antivirals
7.2 Vaccine
7.2.1 Smallpox Vaccine7.2.2 JYNNEOS/Imvanex
7.3 Vaccinia Immune Globulin (VIG)
8. Global Monkeypox Treatment Market, By Product Type, 2019-2032 (USD Million)
8.1 Creams8.2 Gels8.3 Injectable8.4 Ointment8.5 Tablets
9. Global Monkeypox Treatment Market, By Dosage Form, 2019-2032 (USD Million)
9.1 Liquid9.2 Semi Solid9.3 Solid
10. Global Monkeypox Treatment Market, By Route of Administration, 2019-2032 (USD Million)
10.1 Oral10.2 Parenteral10.3 Topical
11. Global Monkeypox Treatment Market, By Age, 2019-2032 (USD Million)
11.1 Adults11.2 Geriatrics11.3 Paediatrics
12. Global Monkeypox Treatment Market, By Gender, 2019-2032 (USD Million)
12.1 Female12.2 Male12.3 Others
13. Global Monkeypox Treatment Market, By Prescription Type, 2019-2032 (USD Million)
13.1 Over the counter (OTC) drugs13.2 Prescription (Rx) drugs
14. Global Monkeypox Treatment Market, By End User, 2019-2032 (USD Million)
14.1 Hospital Pharmacy14.2 Online Pharmacy14.3 Retail Pharmacy
15. Global Monkeypox Treatment Market, By Region, 2019-2032 (USD Million)
15.1 Global Monkeypox TreatmentSize and Market Share by Region (2019-2025)15.2 Global Monkeypox TreatmentSize and Market Share by Region (2026-2032)15.3 Asia-Pacific
15.3.1 Australia15.3.2 China15.3.3 India15.3.4 Japan15.3.5 South Korea15.3.6 Rest of Asia-Pacific
15.4 Europe
15.4.1 France15.4.2 Germany15.4.3 Italy15.4.4 Spain15.4.5 United Kingdom15.4.6 Rest of Europe
15.5 Middle East & Africa
15.5.1 Kingdom of Saudi Arabia15.5.2 United Arab Emirates15.5.3 Rest of Middle East & Africa
15.6 North America
15.6.1 Canada15.6.2 Mexico15.6.3 United States
15.7 Latin America
15.7.1 Argentina15.7.2 Brazil15.7.3 Rest of Latin America
16. Company Profiles
16.1 Bavarian Nordic
16.1.1 Company details16.1.2 Financial outlook16.1.3 Product summary16.1.4 Recent developments
16.2 Chimerix
16.2.1 Company details16.2.2 Financial outlook16.2.3 Product summary16.2.4 Recent developments
16.3 CIDIC Co., Ltd.
16.3.1 Company details16.3.2 Financial outlook16.3.3 Product summary16.3.4 Recent developments
16.4 EMERGENT
16.4.1 Company details16.4.2 Financial outlook16.4.3 Product summary16.4.4 Recent developments
16.5 Hetero
16.5.1 Company details16.5.2 Financial outlook16.5.3 Product summary16.5.4 Recent developments
16.6 Olon S.p.A
16.6.1 Company details16.6.2 Financial outlook16.6.3 Product summary16.6.4 Recent developments
16.7 Piramal Pharma Solutions
16.7.1 Company details16.7.2 Financial outlook16.7.3 Product summary16.7.4 Recent developments
16.8 SIGA Technologies
16.8.1 Company details16.8.2 Financial outlook16.8.3 Product summary16.8.4 Recent developments
16.9 Teva Pharmaceutical Industries Ltd.
16.9.1 Company details16.9.2 Financial outlook16.9.3 Product summary16.9.4 Recent developments
17. List of Abbreviations
18. Reference Links
19. Conclusion
20. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The Monkeypox Treatment Market is projected to reach USD 0.23 billion by 2032, growing at a CAGR of 10.37% during the forecast period.
The Monkeypox Treatment Market grew in market size from 2021. The Market is expected to reach USD 0.23 billion by 2032, at a CAGR of 10.37% during the forecast period.
The Monkeypox Treatment Market CAGR of 10.37% during the forecast period.
You can get the sample pages by clicking the link -Click Here
The Monkeypox Treatment Market size is USD 0.23 billion from 2022 to 2032.
The Monkeypox Treatment Market segment is Covered By Treatment, By Product Type, By Dosage Form, By Route of Administration, By Age, By Gender, By Prescription Type, By End User.
The North America region is anticipated to have the highest market share in the Monkeypox Treatment Market.
The key players in the market include Companies Covered Agility, Almajdouie, Aramex, BAFCO Logistics, Basem International Shipping & Logistics Co. Ltd., DB Schenker, DHL, Fedex-TNT, Hala Supply Chain, Kuehne + Nagel, LSC Warehousing, Mosanada Warehousin, Mubarrad (Saudi Transport & Investment Co.), Naqel Express, Panalpina, Tamer Logistics, United Warehousing Co, Wared Logistics.
The monkeypox virus can cause viral infection in people with weakened immune systems. Increase in numerous chronic illnesses and dermatological conditions like eczema, which causes weakened immunity and increases the risk of contracting the monkeypox virus, leads to the expansion of the monkeypox market.The market expansion of monkeypox treatments is supported by increased research and development for the treatment of monkeypox as well as rising global demand for the therapy.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
